Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Health Catalyst (HCAT) EBT (2018 - 2026)

Health Catalyst filings provide 9 years of EBT readings, the most recent being -$110.6 million for Q1 2026.

  • On a quarterly basis, EBT fell 370.15% to -$110.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$264.3 million, a 266.01% decrease, with the full-year FY2025 number at -$177.3 million, down 156.27% from a year prior.
  • EBT hit -$110.6 million in Q1 2026 for Health Catalyst, down from -$90.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$13.4 million in Q2 2024 to a low of -$110.6 million in Q1 2026.
  • Median EBT over the past 5 years was -$30.2 million (2023), compared with a mean of -$36.3 million.
  • Biggest five-year swings in EBT: surged 58.66% in 2024 and later tumbled 370.15% in 2026.
  • Health Catalyst's EBT stood at -$35.7 million in 2022, then grew by 15.55% to -$30.2 million in 2023, then soared by 33.55% to -$20.0 million in 2024, then crashed by 352.14% to -$90.6 million in 2025, then fell by 22.03% to -$110.6 million in 2026.
  • The last three reported values for EBT were -$110.6 million (Q1 2026), -$90.6 million (Q4 2025), and -$22.2 million (Q3 2025) per Business Quant data.